Data / Drug companies / Foundation Consumer Healthcare
Foundation Consumer Healthcare: 20 products in the FDA NDC directory, labeler code 69536
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Foundation Consumer Healthcare (labeler code 69536) lists 20 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 20 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 31, 2024.
The request: Watch Foundation Consumer Healthcare (FDA labeler code 69536): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 69536
- Products in commercial distribution
- 20
- Packages
- 31
- Finished drugs by generic name
- 9
- Prescription products
- 0
- Over the counter products
- 20
- Flagged as original packager
- 20 of 20 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 1
- Earliest marketing start
- February 17, 2017
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 13 | 65% |
| Authorized generics (NDA) | 3 | 15% |
| New drug applications (NDA) | 2 | 10% |
| Generic drugs (ANDA) | 2 | 10% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 20 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Levonorgestrel | 5 | 31 |
| Camphor (synthetic) and phenol | 3 | 1 |
| Diphenhydramine hydrochloride | 2 | 127 |
| Loratadine | 2 | 125 |
| Aspirin | 2 | 134 |
| Ephedrine sulfate | 1 | 26 |
| Acetaminophen, diphenhydramine hydrochloride | 1 | 14 |
| Brompheniramine maleate, dextromethorphan hydrobromide | 1 | 18 |
| Brompheniramine maleate | 1 | 2 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 5 | 25% |
| Solution | 4 | 20% |
| Tablet, chewable | 2 | 10% |
| Gel | 2 | 10% |
| Kit | 2 | 10% |
| Tablet, orally disintegrating | 2 | 10% |
| Tablet, coated | 1 | 5% |
| Tablet, film coated | 1 | 5% |
| Liquid | 1 | 5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Alavert Allergy | 69536-195 | Tablet, orally disintegrating | Generic drugs (ANDA) | October 31, 2024 |
| Dimetapp Cold and Allergy | 69536-305 | Solution | Over the counter monograph drugs | June 15, 2024 |
| Dimetapp Cold and Cough and Dimetapp Nighttime Cold and Cough | 69536-365 | Kit | Over the counter monograph drugs | June 1, 2024 |
| Dimetapp Cold and Cough and Nighttime Cold and Cough | 69536-355 | Kit | Over the counter monograph drugs | June 1, 2024 |
| Dimetapp Nighttime Cold and Cough | 69536-345 | Solution | Over the counter monograph drugs | June 1, 2024 |
| Dimetapp Multi-Symptom Cold and Flu | 69536-335 | Solution | Over the counter monograph drugs | June 1, 2024 |
| Dimetapp Cold and Cough | 69536-315 | Solution | Over the counter monograph drugs | June 1, 2024 |
| Alavert Allergy | 69536-190 | Tablet, orally disintegrating | Generic drugs (ANDA) | May 1, 2024 |
| Dimetapp Cough and Allergy | 69536-370 | Tablet, chewable | Over the counter monograph drugs | April 15, 2024 |
| Campho-Phenique Antiseptic | 69536-109 | Gel | Over the counter monograph drugs | November 15, 2021 |
| Bronkaid Max | 69536-250 | Tablet, coated | Over the counter monograph drugs | September 1, 2020 |
| Next Choice One Dose | 69536-133 | Tablet | Authorized generics (NDA) | June 15, 2019 |
| Take Action | 69536-200 | Tablet | Authorized generics (NDA) | May 10, 2018 |
| Plan B One-Step | 69536-162 | Tablet | New drug applications (NDA) | May 10, 2018 |
| Plan B One-Step | 69536-146 | Tablet | New drug applications (NDA) | May 10, 2018 |
| Aftera | 69536-103 | Tablet | Authorized generics (NDA) | May 10, 2018 |
| Campho-Phenique Cold Sore Treatment | 69536-108 | Gel | Over the counter monograph drugs | August 1, 2017 |
| Campho-Phenique Antiseptic | 69536-110 | Liquid | Over the counter monograph drugs | June 1, 2017 |
| St. Joseph Chewable Low Dose Aspirin | 69536-281 | Tablet, chewable | Over the counter monograph drugs | February 17, 2017 |
| St. Joseph Low Dose Aspirin | 69536-181 | Tablet, film coated | Over the counter monograph drugs | February 17, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.